← Back to Clinical Trials
Recruiting NCT06834646

NCT06834646 Comparison of 30-day Morbidity and Mortality in Cancer Patients Based on Emergency Department Location

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06834646
Status Recruiting
Phase
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Cancer
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2025-04-12
Primary Completion 2026-09

Trial Parameters

Condition Cancer
Sponsor Assistance Publique - Hôpitaux de Paris
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-04-12
Completion 2026-09

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Patients being followed for cancer account for 2.8% of emergency admissions in France. An acute episode that triggers a visit to the emergency department may be related to the progression of the disease, or to complications of treatment. The management of these patients is often complex and requires a degree of expertise. Emergency departments specialising in the management of cancer complications have been set up, and now deal exclusively with patients treated at their centres. However, for geographical or logistical reasons, patients with cancer are likely to consult a non-specialist emergency department and/or one located outside the cancer care centre. In this case, the emergency doctor may not have access to the oncology file, and care in the emergency department and downstream services may be sub-optimal. Studies have shown a positive impact on the quality of care and prognosis of patients thanks to the cancer centre's expertise. However, the effect of the centre on a cancer patient who visits the emergency department has never been studied. This is particularly true if the emergency department where the patient is seen is located in the cancer follow-up centre. The primary objective of the COVER study is to investigate the impact of the location of the emergency department where the patient is seen for their prognosis.

Eligibility Criteria

Inclusion Criteria: Patients aged 18 or over admitted to an emergency department with cancer that has been active or in remission for less than a year. Exclusion Criteria: \- Opposition to participate in the study

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology